Analysts expect that Rayonier Inc. (NYSE:RYN) will announce sales of $198.30 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have provided estimates for Rayonier’s earnings, with the lowest sales estimate coming in at $186.10 million and the highest estimate coming in at $210.50 million. Rayonier reported sales of $194.70 million during the same quarter last year, which indicates a positive year-over-year growth rate of 1.8%. The business is expected to report its next quarterly earnings report on Wednesday, August 1st.
On average, analysts expect that Rayonier will report full year sales of $774.40 million for the current financial year, with estimates ranging from $756.40 million to $792.40 million. For the next year, analysts expect that the business will report sales of $807.25 million per share, with estimates ranging from $780.40 million to $834.10 million. Zacks’ sales calculations are an average based on a survey of research firms that that provide coverage for Rayonier.
Top 5 Stocks To Own Right Now: Noodles & Company(NDLS)
- [By Demitrios Kalogeropoulos]
It might seem odd that the industry’s biggest winner so far this year isn’t growing. In fact, Noodles & Co. (NASDAQ:NDLS) recently posted a quarterly net loss while revenue decreased 5%. But that result still shot past investors’ expectations by showing surprising progress in the casual-dining chain’s recovery efforts. Noodles & Co. has lots of work ahead of it before it can snap out of its four-year stretch of annual net losses. Yet, with shares having fallen by over 80% since 2013, even modestly good news proved to be enough to spark at least a short-term rally in the stock.
- [By Dan Caplinger]
The stock market finished mixed on Friday, with the Dow Jones Industrial Average gaining ground even as some broader benchmarks finished closer to unchanged for the day. In the absence of major news, investors seemed content to let positive trends from earlier in the week continue to play out, anticipating a favorable end to the first-quarter earnings season and hoping for more progress on the macroeconomic and geopolitical fronts to defuse potential controversies. Some good reports from several corners of the market also helped lift sentiment. The Trade Desk (NASDAQ:TTD), Noodles & Co. (NASDAQ:NDLS), and Regeneron Pharmaceuticals (NASDAQ:REGN) were among the best performers on the day. Here’s why they did so well.
- [By Lisa Levin] Gainers
The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69
Top 5 Stocks To Own Right Now: Cabot Corporation(CBT)
- [By Stephan Byrd]
CommerceBlock (CURRENCY:CBT) traded up 0.7% against the US dollar during the 24 hour period ending at 20:00 PM Eastern on July 3rd. CommerceBlock has a market capitalization of $4.08 million and approximately $16,089.00 worth of CommerceBlock was traded on exchanges in the last day. During the last seven days, CommerceBlock has traded 13.8% lower against the US dollar. One CommerceBlock token can now be bought for approximately $0.0235 or 0.00000363 BTC on cryptocurrency exchanges including OKEx and IDEX.
- [By Joseph Griffin]
Sei Investments Co. increased its position in shares of Cabot Corp (NYSE:CBT) by 137.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,527 shares of the specialty chemicals company’s stock after acquiring an additional 40,219 shares during the quarter. Sei Investments Co. owned approximately 0.11% of Cabot worth $3,874,000 as of its most recent filing with the Securities and Exchange Commission.
- [By Taylor Cox]
Analyst/investor days for: PayPal Holdings, Inc (NASDAQ: PYPL), Cabot Corporation (NYSE: CBT), S&P Global Inc (NYSE: SPGI), Total System Services, Inc (NYSE: TSS), and TTM Technologies, Inc (NASDAQ: TTMI)
Roku, Inc (NASDAQ: ROKU) annual shareholder meeting
Equifax Inc (NYSE: EFX) will meet with investors in L.A.
- [By Lisa Levin]
Companies Reporting After The Bell
Hertz Global Holdings, Inc. (NYSE: HTZ) is projected to post quarterly loss at $1.31 per share on revenue of $1.97 billion.
International Flavors & Fragrances Inc. (NYSE: IFF) is estimated to post quarterly earnings at $1.59 per share on revenue of $909.36 million.
Zillow Group, Inc. (NASDAQ: ZG) is expected to post quarterly earnings at $0.06 per share on revenue of $294.79 million.
General Cable Corporation (NYSE: BGC) is estimated to post quarterly earnings at $0.15 per share on revenue of $980.61 million.
Central Garden & Pet Company (NASDAQ: CENT) is expected to post quarterly earnings at $0.84 per share on revenue of $598.45 million.
Cabot Corporation (NYSE: CBT) is estimated to post quarterly earnings at $1 per share on revenue of $746.42 million.
Fabrinet (NYSE: FN) is expected to post quarterly earnings at $0.71 per share on revenue of $319.71 million.
National General Holdings Corp. (NASDAQ: NGHC) is projected to post quarterly earnings at $0.55 per share on revenue of $1.08 billion.
The Navigators Group, Inc. (NASDAQ: NAVG) is estimated to post quarterly earnings at $0.75 per share on revenue of $320.92 million.
Diplomat Pharmacy, Inc. (NYSE: DPLO) is expected to post quarterly earnings at $0.22 per share on revenue of $1.29 billion.
Trex Company, Inc. (NYSE: TREX) is projected to post quarterly earnings at $1.19 per share on revenue of $172.22 million.
AMC Entertainment Holdings, Inc. (NYSE: AMC) is expected to post quarterly earnings at $0.09 per share on revenue of $1.35 billion.
Envision Healthcare Corporation (NYSE: EVHC) is projected to post quarterly earnings at $0.64 per share on revenue of $2.02 billion.
Regal Beloit Corporation (NYSE: RBC) is estimated to post quarterly earnings at $1.23 per share on revenue of $869.64 million.
Amedisys, Inc. (NASDAQ: AMED) is projected to post quarterly earnings at $0.67 per share on revenue of $39
- [By Logan Wallace]
Scopus Asset Management L.P. lifted its position in shares of Cabot Corp (NYSE:CBT) by 74.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 435,000 shares of the specialty chemicals company’s stock after buying an additional 185,000 shares during the quarter. Scopus Asset Management L.P.’s holdings in Cabot were worth $24,238,000 at the end of the most recent quarter.
Top 5 Stocks To Own Right Now: AMAG Pharmaceuticals, Inc.(AMAG)
- [By Chris Lange]
AMAG Pharmaceuticals Inc. (NASDAQ: AMAG) has a PDUFA date set for its drug Feraheme for the treatment of iron deficiency anemia in patients who have an intolerance or unsatisfactory response to oral iron. The date is set for February 2. Shares of AMAG were trading at $14.45, in a 52-week range of $11.93 to $25.20 and with a consensus price target of $18.00.
- [By Stephan Byrd]
AMAG Pharmaceuticals (NASDAQ:AMAG) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued on Monday.
- [By Logan Wallace]
AMAG Pharmaceuticals (NASDAQ:AMAG) was downgraded by equities researchers at BidaskClub from a “strong-buy” rating to a “buy” rating in a research report issued on Monday.
Top 5 Stocks To Own Right Now: Euro Tech Holdings Company Limited(CLWT)
- [By Lisa Levin]
Euro Tech Holdings Company Limited (NASDAQ: CLWT) was down, falling around 7 percent to $3.745 after dropping 30.26 percent on Friday.
- [By Lisa Levin] Gainers
Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 34.7 percent to $45.50 in pre-market trading following news that the FDA has approved Andexxa for the reversal of factor Xa inhibitors.
Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 15.7 percent to $6.65 in pre-market trading after climbing 155.56 percent on Thursday.
China Recycling Energy Corporation (NASDAQ: CREG) rose 14.7 percent to $2.75 in pre-market trading after climbing 57.89 percent on Thursday.
Pandora Media, Inc. (NYSE: P) rose 11 percent to $6.40 in pre-market trading after reporting strong quarterly results.
Fred's, Inc. (NASDAQ: FRED) rose 9.2 percent to $1.90 in pre-market trading following Q4 results.
Shake Shack Inc (NYSE: SHAK) rose 9.1 percent to $51.70 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY18 guidance.
Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) rose 9 percent to $12.55 in pre-market trading after the company posted Q1 results and agreed to acquire HealthGrid.
Weight Watchers International, Inc. (NYSE: WTW) rose 7.6 percent to $75 in pre-market trading after the company reported stronger-than-expected results for its first quarter. The company also raised its FY18 earnings outlook from $2.40-$2.70 to $3-$3.20.
Viavi Solutions Inc. (NASDAQ: VIAV) rose 7.5 percent to $10.15 in pre-market trading following Q3 results.
Pearson plc (NYSE: PSO) rose 4.5 percent to $11.83 in pre-market trading after reporting strong quarterly earnings.
Alibaba Group Holding Ltd (NYSE: BABA) shares rose 4.4 percent to $190.50 in the pre-market trading session as the company posted upbeat Q4 results.
Aqua Metals, Inc. (NASDAQ: AQMS) shares rose 3.9 percent to $4.30 in pre-market trading after gaining 6.98 percent on Thursday.
Newell Brands Inc (NYSE: NWL) shares rose 3.6 percent to $27.65 in pre-market trading after reporting upbeat quarterly earnings.
HMS Holdings Corp (NASDAQ: H
- [By Lisa Levin]
Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares shot up 93 percent to $6.16 after reporting 2017 year-end results.
Shares of SORL Auto Parts, Inc. (NASDAQ: SORL) got a boost, shooting up 13 percent to $5.90 after reporting upbeat Q1 results.
Top 5 Stocks To Own Right Now: Monroe Capital Corporation(MRCC)
- [By Stephan Byrd]
Monroe Capital Corp (NASDAQ:MRCC) Director Jeffrey A. Golman purchased 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, June 20th. The stock was bought at an average cost of $13.62 per share, with a total value of $108,960.00. Following the purchase, the director now owns 10,000 shares of the company’s stock, valued at $136,200. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
- [By Ethan Ryder]
Monroe Capital (NASDAQ:MRCC) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Friday.
- [By Shane Hupp]
Moelis & Co (NYSE: MC) and Monroe Capital (NASDAQ:MRCC) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, risk, institutional ownership, earnings, dividends and analyst recommendations.